Pulmuone has a total of 316 patents globally, out of which 172 have been granted. Of these 316 patents, more than 56% patents are active. South Korea is where Pulmuone has filed the maximum number of patents, followed by United States of America. Parallelly, South Korea seems to be the main focused R&D center of Pulmuone and is also the origin country of the firm.
Pulmuone was founded in the year 1981 by Seung-Woo Nam and Won Hyeyeong. The company is a South Korean firm that produces plant-based foods such as tofu and soybean sprouts.
Do read about some of the most popular patents of Pulmuone which have been covered by us in this article and also you can find Pulmuone patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Pulmuone patent portfolio.
How many patents does Pulmuone have?
Pulmuone has a total of 316 patents globally. These patents belong to 308 unique patent families. Out of 316 patents, 179 patents are active.
How Many Patents did Pulmuone File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant
Pulmuone Applications Filed
Pulmuone Patents Granted
2022
15
12
2021
20
4
2020
19
8
2019
19
14
2018
18
15
2017
21
17
2016
27
14
2015
26
12
2014
29
17
2013
20
11
2012
13
6
2011
13
3
How many Pulmuone patents are Alive/Dead?
Worldwide Patents
How Many Patents did Pulmuone File in Different Countries?
Where are Research Centres of Pulmuone Patents Located?
10 Best Pulmuone Patents
KR1020160017223A is the most popular patent in the Pulmuone portfolio. It has received 14 citations so far.Below is the list of 10 most cited patents of Pulmuone:
The chart below distributes patents filed by Pulmuonein different countries on the basis of the technology protected in patents. It also represents the markets where Pulmuone thinks it’s important to protect particular technology inventions.
R&D Focus: How has Pulmuone search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Pulmuone?
Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be
Relmada Therapeutics has a total of 72 patents globally, out of which 25 have been granted. Of these 72 patents, more than 34% patents are active. The United States of America is where Relmada Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, United
Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to
Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
